SAN

Sanofi News

Company Name Stock Ticker Symbol Market Type
Sanofi SAN Euronext Ordinary Share
  Price Change Change Percent Stock Price Last Traded
0.17 0.2% 85.94 11:40:00
Open Price Low Price High Price Close Price Prev Close
85.69 85.03 86.75 85.94 85.77
more quote information »

Recent News

Date Time Source Heading
12/05/20227:15IHNWFeaturedElectromedical Technologies Announces Financial and Operational Highlights for the Three and Nine Months Ended September 30, 2022
12/02/202201:55GLOBECommuniqué de presse : Annonce de Sanofi au sujet de la..
11/30/202202:00GLOBECommuniqué de presse : Acoziborole : un médicament..
11/17/202213:29DJNSanofi Gets EU Nod on Hemolytic Anemia Drug
11/17/202212:50GLOBECommuniqué de presse: La Commission européenne approuve..
11/14/202217:42GLOBESanofi: Information concerning the total number of voting..
11/11/202207:56DJNRegeneron, Sanofi Get CHMP Backing for Dupixent in Prurigo..
11/11/202207:00GLOBECommuniqué de presse: Le CHMP recommande l’approbation de..
11/10/202210:36GLOBEPress Release: Sanofi and GSK’s next-generation COVID-19..
11/04/202203:52DJNAstraZeneca's Nirsevimab Approved in the EU
11/04/202203:00GLOBEPress Release: European Commission grants first approval..
10/28/202202:01DJNSanofi 3Q Sales Climb; Raises 2022 Business EPS Guidance
10/28/202201:30GLOBEPress Release: Continued strong growth in Q3 with key..
10/13/202215:58GLOBESanofi: Informations relatives au nombre de droits de vote..
10/11/202201:00GLOBECommuniqué de presse: Des données de phase III de dernière..
10/06/202211:03DJNProvention Bio Shares Rise 21% After Co-Promotion Agreement..
10/06/202208:10DJNProvention Bio, Sanofi Set Co-Promotion Pact for Teplizumab..
9/30/202215:11DJNCorrection to Sanofi and Regeneron Pharmaceuticals Article..
9/28/202219:05DJNSanofi, Regeneron Say Dupixent Gets FDA Approval to Treat..
9/28/202218:05GLOBECommuniqué de presse: Dupixent® (dupilumab), premier et seul..
9/28/202201:30GLOBEPress Release: Availability of the Q3 2022 Memorandum for..
9/16/202202:45DJNAstraZeneca Says Nirsevimab Recommended for Approval in EU
9/16/202202:00GLOBECommuniqué de presse: Le CHMP recommande l’approbation de..
9/13/202215:24GLOBESanofi: Information concerning the total number of voting..
9/08/202211:30GLOBECommuniqué de presse: Des données de phase III de dernière..
8/31/202214:30GLOBECommuniqué de presse: XenpozymeTM (olipudase alfa-rpcp)..
8/30/202202:28DJNSanofi Hemophilia Drug Granted Priority Review by U.S. FDA
8/30/202201:30GLOBECommuniqué de presse: La FDA accorde un examen prioritaire à..
8/17/202208:02DJNTrending: Sanofi Stops Development of Breast-Cancer Drug..
8/17/202204:15DJNSanofi Shares Drop After End of Development Program for..
8/17/202202:39DJNSanofi Stops Development Program for Breast-Cancer Treatment..
8/17/202201:30GLOBECommuniqué de presse: Sanofi fait le point sur le programme..
8/12/202204:48DJNGSK, Sanofi, Haleon Shares Recover Some Recent Losses After..
8/12/202203:30DJNHaleon Says It Hasn't Been Notified About Litigation on..
8/10/202215:29DJNSanofi Down Nearly 8%, On Track for Largest Percent Decrease..
8/08/202215:03GLOBESanofi: Information concerning the total number of voting..
8/04/202212:36DJNSanofi, Innovent Biologics to Collaborate on Oncology..
8/04/202211:30GLOBECommuniqué de presse : Sanofi et Innovent Biologics nouent..
7/28/202208:29GLOBECommuniqué de presse : Mise en ligne du rapport financier..
7/28/202202:05DJNSanofi Upgrades Fiscal Year Guidance as 2Q Sales Rose 16%
7/28/202201:30GLOBEPress Release: Strong execution in Q2 drives full-year 2022..
7/20/202212:52GLOBESanofi: Information concerning the total number of voting..
7/14/202201:00GLOBEPress Release: Dupixent® (dupilumab) Phase 3 trial shows..
7/10/202209:45GLOBEDes données pivots démontrent que l’efanesoctogog alpha une..
7/04/202206:00GLOBESanofi Global Health launches nonprofit Impact® brand for 30..
6/30/202211:42DJNSanofi on Pace for Largest Percent Decrease Since April 2020..
6/30/202206:29DJNSanofi's Phase 3 Trials of Multiple Sclerosis Drug Partially..
6/28/202201:30GLOBECommuniqué de presse: Xenpozyme® (olipudase alpha) approuvé..
6/27/202216:57GLOBESanofi: Informations relatives au nombre de droits de vote..
6/24/202214:05DJNSanofi On Pace for Largest Percent Increase Since November..
6/24/202202:21DJNSanofi, GSK Report Successful Vaccine Study Against Omicron